z-logo
Premium
LPS pretreatment reprograms macrophage LPS‐stimulated TNF and IL‐1 release without protein tyrosine kinase activation
Author(s) -
West Michael A.,
Bennett Terriel,
Seatter Susan C.,
Clair Laurel,
Bellingham Janet
Publication year - 1997
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1002/jlb.61.1.88
Subject(s) - cytokine , biology , tumor necrosis factor alpha , tyrosine kinase , macrophage , microbiology and biotechnology , cancer research , signal transduction , immunology , biochemistry , in vitro
Pretreatment of macrophages with low‐dose endotoxin (LPS p ) profoundly alters cytokine release in response to subsequent LPS a activation. These qualitative and quantitative alterations in cytokine release have been termed macrophage reprogramming. Macrophage activation by LPS is thought to occur via a mechanism involving an early protein tyrosine kinase (PTK) phosphorylation step. PTK inhibition with genistein or herbimycin A blocks LPS a ‐stimulated secretion of tumor necrosis factor (TNF) and interleukin‐1 (IL‐1). In this study we investigated whether a PTK pathway participates in LPS p pretreatment reprogramming. We show that LPSp pretreatment inhibited TNF and augmented IL‐1 release in response to subsequent LPS a stimulation. Blockade of PTK activation pathways during the interval when macrophages were exposed to LPSp prevented mitogen‐activated protein kinase phosphorylation, as well as LPS p ‐stimulated release of TNF and IL‐1, but did not block LPS p reprogramming effects. We conclude that LPS p pretreatment reprogramming of macrophage cytokine production does not require PTK activation. J. Leukoc. Biol . 61: 88–95; 1997.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom